FDA approves Pfizer's biosimilar for inflammatory diseases
April 5 (Reuters) - Pfizer Inc's drug for multiple inflammatory diseases was approved in the United States, making it the second biosimilar to be approved by the U.S. Food and Drug Administration.
No comments:
Post a Comment